{
  "folder": "IC-187",
  "content": "{{knowledge objective\n|Identifiant=OIC-187-07-A\n|Item_parent=Hypersensitivity and mucocutaneous allergies in children and adults. Urticaria, atopic and contact dermatitis\n|Item_parent_short=Hypersensitivity and mucocutaneous allergies in children and adults. Urticaria, atopic and contact dermatitis\n|Rank=A\n|Title=Knowing how to treat acute urticaria\n|Description=None\n|Rubric=Management\n|Contributors=\n|Order=7}}\n- '''Etiological treatment'''\n\nAvoidance of favouring/triggering factors\n\n- '''Symptomatic treatment'''\n\n2<sup>th</sup> generation anti-H1 antihistamines 1 to 2 tablets/day.\n\nIn the event of chronic acute urticaria and/or poor response; 2nd<sup>th</sup> generation anti H1 antihistamines may be increased to 4 tsp/day.\n\n\nIn the event of associated signs of anaphylaxis, treatment should be guided by the symptoms presented;\n\n\u00d8 Parenteral adrenaline in cases of anaphylactic shock or asphyxiant angioedema,\n\n\u00d8 Oxygen therapy if desaturation,\n\n\u00d8 vascular filling if anaphylactic shock,\n\n\u00d8 administration of inhaled beta-2 mimetics in the event of bronchospasm.",
  "question": {
    "question": "What is the recommended treatment for acute urticaria?",
    "option_a": "Avoidance of favouring/triggering factors",
    "option_b": "First-generation anti-H1 antihistamines",
    "option_c": "2nd generation anti-H1 antihistamines 1 to 2 tablets/day",
    "option_d": "Parenteral adrenaline in cases of anaphylactic shock or asphyxiant angioedema",
    "correct_option": "C"
  }
}